L latroductien
Protein post-translational modification is a method cells use to regulate their response to external and internal stimulL A conunon post-translational modification employed in this regulatory mechanism k prorein pbospborylation. Protein phnspherylation states can regulate enzyme activity as well as the cellular location of proteins. Cells adjust the phosphate levels of specific proteins through the action of kinases and phosphatases. Phosphorylation-dephosphorylation mechanisms predominantly alter the state of Ser or Thr phosphorylation in proteins. Similar modifications of Tyr have only recently been studied. Although this review will focus predominantly on tyrosine dephospborylation, it is necessary to briefly review the history of tymsine pbosphoulation. Before 1980 the only regulatory pbosphoamino acids identified in proteins were phosphoserine and phnsphothreonine. Ser and Thr protein pbosphorylation states regulate many metabolic processes (reviewed in Ref. 1). In 19~0 a unique catalytic activity was discovered while examining v-src, the . Analysis of cellular phosphoamino acid content revealed that phosphotyrosine accounts for only 0.01-0.05% of cellular pbosphoamino acids in normal tissue culture cells [2] . However, this content increases to 1-3% of total cellular pbospboan~ino acids upon transformation by oncogenic retroviruses [5] . The increase in tyrosine phosphorylation upon viral transformation suggested that tyrosine kinases may be linked to the removal of growth restraint from cells. Investigations of oncogenes from other tumorigenic viruses showed that many of these proteins also displayed tyrosine kinase activity (reviewed in Ref. 6 ). The mechanism of growth factor receptor activation was under investigation at the same time that the discoveries of viral tyrnsine kinase activity were being made. Sm-prisingly, one of the growth factor receptors (epidermal growth factor) was also shown to ha~e tyrosine kinase activity [7] . This identification of a non-viral tyrosine kinase which controi~ :e!! growth suggested that tyrosine phosphorylation was important in the physiology of non-transformed cells.
The primary sequence of protein tyrosine kinases had been identified through the cloning and sequencing of viral and cellular oncogenes (reviewed in Ref. 8) . Progress in our understanding of tyrnsine kinases was rapid and the fOCUS on phnspborylation events domi-hated this period of progress. Few investigators were attempting to understand the imvortance of tyrosioe deplmsphoulation events (see review in Ref. 9)i. Progress shm'lar to that made with the tyrosin¢ kinases was not possible with the protein tyrosine phnsphatases (PTPase, EC 3.13.48) since the pure preparation of PTPase and the corresponding amino acid sequence was not avai [ab~ until 1988 [11] when PTPase 1B was purified from human placenta [12] . The partial amino acid sequence of PTPase IB [12] yielded two surprises. First, tyrusine-specific phosphatase had no sequence sinfilarity to any of the previously characterized serine and thr~.-onine phusphatases, suggesting that PTP 1B was a member of a different family of proteins. Second, a search of known protein sequences revealed that PTPase 1B contained a region of similarity to a major lymphocyte cell surface glycoprotein termed C!~5. C[~5 is a "receptor-like molecule" present on the lymphocyte cell surface and is composed of a highly glycosylatcd, differentially spliced extracellular domain, a single ~mbrane domain, and a cytosolic domain containing two repeats of a 200-amino-acid sequence showing sequence identity to PTP lB. At the time this comparison was made, no function for CD45 had been determined, but studies using antibodies directed against its extraceDular domain suggested that CD45 was involved in early lymphocyte activation (reviewed in Ref. 13 ). The shmlarity between CIM5 and PTPase IB not only suggested a function for the cytoplasmic domain of CD45, but also supported the idea that PTPases possessed a signalling function.
1L Mulecular Mele~ ef the PTPuses
The initial identification of two members of the PTPase family (i.e, PTP IB and CIM5) led to the ckming of numerous other PTPases. These were obtained either through low-stringency screening of cDNA h'braries [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] or by the use of the polymerase chain reaction (PCR) using oligonucelotide primers desiga :d from conserved amino acid sequences within the PTPases [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . Additional PTPases were identified through sequence similarities to the conserved "active-site' regions of *,he PTPases (the "HCSAGVGR (S/T)G' mc,~, [_~,43-5o] .
Sequence analysis of these clones showed that they eitber resembled PTPase IB or CD45. PTPase IB is a representative of the "nonreceptor-like' class of PTPases that have only one copy of the 200-amino-acid conserved PTPase domain and no transmembrane spanning region. Fig. 1 is a schematic diagram of the nonreceptor-like PTPases. The diverse structures of z For a deta~d awmmt of the enzTmology of tyrosine phosphatases prior to 1988 the reader is directed to an excellent review by Brautigan [10] . [25, 40, 41] . n~pHl [34] . ~ [33] . P~pl [31] , Yseptpl [32] . Yscptp2 [96] . YopSl [20] . Vhl [49] . Hcdc25 [48] , Yspcdc25 [44] ,
these molecules suggest multiple methods of regulation. CD45 is a representative of_ the "receptor-like" class of PTPases that have, with two exceptions (PTPase /3 [23] ; and DPTP10D [36,37D, tandem 200-amino-acid PTPase cytnso]ic repeats and variably sized extracellular domains separated by a single transmembrane spanning region. A review on the qructore and potentiai function of these receptor-like molecules has appeared [51~ The primary structure of 42 PTI ases has allowed us to construct a family tree by sequence comparison. This tree, created by performing multiple progressive sequence alignments of each 200-amino-acid conserved region (blackened area in Fig. 1 ) and clustering related sequences [52] , provides a non-biased grouping of the PTPases. The result, shown in Fig. 2 Guan et al., unpublished). Results similar to those presented here were described by Krueger et al. using a much smaller database [23] .
One difficulty that has arisen due to the rapid cloning of PTPases is the lack of a defined system of nomenclature. For example, there are two different reports of clones named PTPase a,/3 and 3' [21, 23] . By chance, both a and 3' are identical but, as seen in Fig.  2 , a subscript is needed to differentiate the two /3 molecules. Some discussion of a nomenclature system has taken place at the Annual Protein Phosphamse meeting in Brussels (Sept. 1991). Even though no final system of nomenclature was adopted, a naming system using 'R' as a prefix for receptor-like molecules and no 'R' for nonreceptor-like molecules was suggested. It was further proposed that each PTPase would be given a unique number or letter (or both) assigned in the order cloned. Therefore, with this system, CIM5 would be renamed RPTPase 1, and PTPase 1B would be called PTPase 1. No matter what system is chosen, some method of systematic nomenclature is badly needed.
As Fig. I indicates, most PTPases contain functionally important sequences other than the conserved 200-amino-acid PTPase domain. By comparison of these sequences with other known protein sequences potential functions can be suggested for these regions of the PTPases. When human LAR was cloned [47] , both the intraccllular and extracellular domains had no known function. The cytoplasmic domain's similarity to PTPase IB suggested a function for this part of the molecule. Streuli and collaborators, upon analysis of the extracellular region of this molecule, noted that it possessed similarities to the ligand-binding region of the neural cellular adhesion molecule, N-CAM. Extracellular regions of N-CAM interact in a homophilic manner to influence neuronal development [53] . Since LAR is expressed on the surface of all solid type tissues and contains within its cytoplasmic domain a phosphatase region, this molecule is proposed to be responsible for the contact inhibition of cell growth [15] . Homophilic interactions between LAR molecules located on adjacent cells may cause an increase in LAWs phosphatase activity, a decrease cellular ph~-pbotyrosine content and may thus stop cell growth. Although this is a particularly attractive suggestion, it should be pointed out that we have a very poor understanding of the function of the extra~ellular domain of the PTPases.
Another sequence similarity that was discovered within the Fl'Pases is in the SH2 domains of PTPlc [25, 40, 41] . Research by many groups has shown that these 100-amino-acid regions specifically bind tyrosinephosphorylated proteins (reviewed in Ref. 54 ). Analysis by Sben and coworkers has shown that the SH2 domains of PTPlc are functional [25] . This suggests that PTPlc may use these regions to bind substrates or Ioeafize to specific subceHular locations, as suggested for other SH2-containing proteins [55] . Two other PTPases, Hptpmeg and HptpHI, contain a region that shows 20-35% similarity to a region contained in :hree cytoskeletal proteins, band 4.1, ezrin and talin [33, 34] . These regions in these cytoskeletal protvins are nccessa~ for asso~-iation with other cytoskeletal proteins. Therefore this similarity suggests that the two lrrPases, termed Hpipmeg ane HptpHI, use these sequences to localize themselves to the cytoskeleton and thereby define specific substrates for these PTPases.
Specific amino acid sequences located near the Cterminus of several of the noareceptor-like FIVases appear to be important ha subceHular localization of the phosphatases. Since these sequences appear to play important roles ha the intraceHular localization of the PTPases, they h'kely function to define or limit the substrate specificity of the PTPases. DetaiLs of these C-terminal sequences and their function will be dascribed later in this review (see Section IV, Biology of the 7FPases).
The gene expression pattern of PTPases also suggests specific function. Many of the PTPases are Oroadly distributed ha various cell t~es; others, however, have quite specific extnession patterns. CI~5 has long been known to be expremed only in lymphocytic cells [13] . The striatum enriched phosphaLase, as its name irais expressed in a highly selective manner in the brain's striatum [24] . Selective expression of three Drosoph/la receptur-like PTPases in embffonal central nermus system axons suggests their role in axon outgrowth and guidance [36] [37] [38] . PTPase 1 is strongly expressed in the hippocampus [16] , a region of the brain known to be important ha long-term potentiation and memory. In-situ staining fur PTPase activity ha the brain using o-phoxpho-L-t3~a~ine as a substrate [56] confirmed that the hippocampus is a region of the brain rich in PTPases.
IlL Stractare and fw~fioa stadie~ of the PrPases
Expression of cloned PTPases in a variety of prokat3~m~ and eukaryotic .systems has provided sufficient quantities of protein for structure/function studies. Using the large database of PTPase sequences, highly conserved residues within the PTPase family can be identified and mutated to examine their importance in catalysis and stability. Deletion mntagenesis can be used to determine the importance of vario:=s ~gions :,f the molecule. Finally, kinetic analysis and chemical modification of the PTPases can he used to evaluate their mechanism(s) of catalysis.
Two sequence motifs present in kinases and debydrogenases appear to he conserved in many of the phosphatases. The fu'st sequence is the GXGXXG motif in the "active-site region" [HCSAGVC'-R(S/TK;] of the PTPases. As noted by Pot et al. and Guan et al.
[2832], this motif is also present in dehydrogenases [57] and protein kinases [58] and is located at or near the active site of these enzymes. Modification of the first glycine ha the sequence to any other residue eliminates human LAR PTPase activity [59] suggesting that the motif is critical to p.hosphat.~se structure or functi,,n. The lnesence of this motif suggests that structural features within this region of :he PTPases are similar to structures of either the dalrydrogenases or the kinases. It has recently been noted that the GXGXXG motifs are tuuetionally different ~Ja dehydrogenases and kinases [60] , It will be interesting to determine the functional role of this motif ha the PTPases.
The. seared conserved motif, that appears in the T-cell and PTPase 1 subfamily of the nonoVhl-like PTPases, is the FKVRES sequence [28] . This sequence is located just upstream from the conserved "HCSAGVGR(SfDG" motif of the PTPases. The FLVRES sequence corresponds to the most highly conserved region of the phosphotyrusine-binding SH2 domain of the Src t~Tosine kinase family [54] . The FLVRES sequence ha c-src may be associated with cell-specific oueogenes~ as mutation of these residues modifies the transformation pattern of two cell lines from different species [61.62] . It is tempting to speculate that PTPases that contain this sequence, which is invariably located close to the active site of the PTPase, also utilize these amino acids in phosphotyrosine binding.
Because phosphoe~ine content of cells is maximally 3% of total cellular phoxphoamino acids, even in transformed cells [5] , the natural substrates for the PTPases are rare. Therefore most studies of PTPases use proteins that are readily avm'lable in pure form and easily phosphorylatcd on t~rusine. These include proteius such as casein, hi.one, myelin basic protein, and .~iys~.yrne as well as small peptides such as poly (Glu4, Tyr), and anglotensin. All substrates are generally phoxp.horylated on qa~inc in vitro using purified tyrosine kinases. The use of these 'artificial" substrates has made it pos~'ble to rapidly analyze the kinetic properties of the PTPases. However, the use of artif~al substrates limits our under~anding of the "naturally" occuring substrates of the PTPases. Recently, several studi,~ of the PTPases on naturally occuring substrates have been repotted. All but the Vhi family of phosphatases catalyze the removal of phosphate from ~osLn_e and not serine-or threoniue-containing substrates. Demonstrating serine and threonine phosphat~.~ activity in the ~"ui i'~tdiy c~ P'l'Pases first documented that this family of enzymes did not have a tyrusinc-restricted substrate specificity, in addition, the fact that Vhl showed sequence identity to cdc25 provided the fu-st suggestion that cdc25 was a phosphatase which tamld dephosphorylate p34 'x~. The sequence similarity between the two molecules also provided a rationale for testing the phosphatnse activity of cdc25 in vitro and in vivo [63, 64] .
The insulin receptor tyrosine kinase has been an attractive 'naturally" oomring substrate for the PTPases. Autopbospbofflation of the insulin receptor /t subunit specifically in the region surrounding amino acid 1150, activates the insulin receptor to phosphorylate other cellular proteins on tyrosine [65] . The regulatory 1 150 region contains three tyrosines, all of which must be pbosphor~ted before trans-kinase activity is poss~le. Levine and coworkers have established that soluble insulin receptor kinase phosphorylates a ~eptide containing these tyrosines in the order 1150, 1151, 1146 [66] . Differences in the dephosphorylation of these tyrosines by four tyrosine phosphatases, human T-cell PTPase, human PTPase 113, human CIM5 and rat LAR, on the same triphosphorylated peptide, have recently been described [67] . The two receptor-like pbosphatas~ CD45 and LAR, remove the phosphates in the rate-dependent order 1146 > 1151 > 1150, essentially reversing the order of phosphotajlation. PTPase IB removes the phosphates in manner, 1150 = 1151 > 1146. T-cell PTPase displays no order of dephusphorylation, removing all phosphates at the same rate. These data implicate substrate specificity as being an important determinant in PTPase catalysis and regulation of substrate specificity. Kinetic studies by Cho et al. [68] support the observations of Ramachandran and workers [67] . They observed that the first domain of human LAR dephosphorylates phosp~ 1146 at least 25 times more efficiently than tyrosine 1150 and 1i51 [68] .
Many compounds modulate the activity of protein tyrosine phosphatases. Probably the most universal is orthovanadate, which effectively inhibits all tyrosine phosphatases so far tested at levels between 10 and 100 /tM. Another unF.~..sal inhibitor is molybdate. Polyanionic spermine and spemidine, EDTA, Mn 2+ and Zn 2+ differentially inhibit the PTPzs~ and can be used to discriminate between phosphatases [28, [69] [70] [71] . From the first purification of PTPases it was noted that thiol reducing agents must be present during their extraction and isolation to preserve their activity [28, 69, 72] . This suggested that a cysteine residue was critical for enzyme activity. To pursue this further, su!phyd~l-directed inhibitors were tested for their ability to inhibit PTPase activity. Pot and coworkers showed that three irreversible inhibito~ N-ethyimaleimide, p-(bydroxymercuri)benzoate and iodoacetate fully inln'bited rat LAR's PTPase acthdty [28] . Equivalent levels of iodoacetamide had no effect on enzyme activity. Analysis of enzyme inactivation at different pHs indicated that the negatively charged iodoacetate interacts with a positive residue at or near the active site of rat LAR, allowing a reactive cysteine to attack and displace 1-from iodoacetate. This was confirmed by experiments using purified rat LAR and ~4C-iodoacetate. lodoacetate binds rat LAR and the binding is in competition with the substrate. Following the irreversible inactivation of LAR with iodoacetate a stoichiometry of 0.8 mol of indoacetate bound per mol of enzyme could be demonstrated [73] . A single 14C-labelled peptide was isolated following proteolytic digestion of LAR, and sequencing of this peptide identified the site of labelling as cysteine 1522, the catalytically essential residue within the central conserved 'HCSAGVGR(S/T)G" PTPase motif. Although there are 11 Cys residues in this protein, only Cys-1522 is labelled, pointing to the unusual reactivity of the active-site thiol residue.
The regulatory effects of phosphorylation on PTPase activity have been examined. CD45 can be readily phosphorylated on serine/threonine by casein kinase 2, protein kinase C, and glycogen synthase kinase 3 in vitro, and on tyrusiue in vivo, but no change in pbosphatase activity could be detected [74, 75] . Rat LAR is also phosphorylated in vitro by protein kinase C and p43 v"~ tyrosine kiuase but no change in activity was noted with either phosphorylation [28] . The only in vivo study showing regulation of a phusphatase by pbosphorylation was done by Ostergaard ~nd Trowbridge [76] . They showed that when T-cells were treated with the calcium ionophores ionomycin or A23187, CD45 PTPase activity decreased by 50-90%. Analysis of the CD45 showed that the drop in activity correlated with a drop in serine phospho~iation. Even though the sites or enzymes responsible for this dephosphorylation were not k2entified, this was the first indication that PTPase activities are regulated by pbosphorylation in vivo.
The large database of similar PTPase sequences enables conserved residues to be identified and mutated to determine their importance in the catalysis of the enzyme. Systematic mutagenesis of conserved cystein residues in the catalytic domains of CD45 by Streuli and coworkers indicated that only the first domain catalyzed the dephospborylation of substrate [15] . Later, a similar conclusion was obtained for human LAR [59] . In this same study other point mutations in the central "HCSAGVGR(S/T)G' motif were created, identifying the critical importance of this region to catalysis. Pot et al. [28] confirmed that greater than 99% of the activity on the substrates tested arises from the first domain of purified recombinant LAR. Either the second domains of CD45 and LAR act solely in a regulatory manner or appropriate substrates for these domains have not been found. Recently both domains of human PTPa have been shown to contain catalytic activity [71] . Differences in substrate specificity, responses to modulators and the interdependence of these two domains are properties likely to be found important in the action of PTPa in vivo.
The ability of a single amino acid mmation to inactivate the PTIPase has been a useful negative control for PTPase function, both in vitro and in vivo. Mutation of the ojsteine contained in the central PTPase signature motif was used to establish the specificity of PTPase I [77] , LAR [28] , cdc25 [63, 64] , the bacterial PTPase in vitro [20] , and in vivo [78] . This unique and simple raethod should be of great utility in future studies of the functional significance of PTPases.
Random chemical mutaganesis has also been utilized to study the stability of PTPases. Tsai and coworkers, using hydrox3"lamine and N-methyl-N: nitro-N-nitrosogoanidine, mutated the first cytoplasmic PTPase domain of human LAR and screened for temperature-sensitive and thermostable mutants [79] . This anal~is identified 8 temperature-sensitive mutants ~l~-tcred in ae 80-~acid re,on in the first half of the molecule. The grouphtg of these temperature-sensitive mutants identified a region of this PTPase, highly conserved in other PTPases, that probably is critical for initial folding and stability of the protein. Interestingly, a mutation that causes increased stability and solubility of temperature-sensitive human LAR mutations (C1446-Y) occurs naturally in the rat homologue of LAR and may account for the excellent solubility and stability of the latter enzyme [2S].
The studies descn'bed abo~e all suggest that the c~teine in the "HCSAGVGR(Sfff)G' motif is an important residue used by PTPases to remove phosphate from phosphoprotains. Kinetic and chemical analysis of the action of PTPases has allowed a probable mechanism of enzyme action to he identified. Guan and Dixon [77] and Pot et at. [28] utilized a rapid denaturation technique to trap a radioactively lahelled phosphocysteine i~termediate of rat PTPase I and L0,R. Formation of this intermediate was transient and dependent nn the presence of the catalytically important cystaine. Walsh and his colleagues have also detected a 32P-labelled phosphoprotein and have eloquently documented an LAR PTPase catalyzed tsO exchange into phosphate from water [80] . Collectively, these observations along with work of Zhang and Dixon (unpublislmd) point to the PTPases utilizing the suggested mechanism outlined in Fig. 3 . The nucleophilic cysteine (of the PTPase signature motif) attacks the phosphate of the phosphotyrosinc protein substrate, releas~ ing the dephosphopjlatad protein substrate and forming a thiolphosphata enzyme intermediate. In the second step of the reaction~ wat.er ~ttacks this intermediate, regenerating active enzynm and releasing the second l:.-nyJuct, inorganic phosphate. Kinetic data and "trapping" of the phospho-enzyme intermediate suggests that the second step in the reaction is rate detarmining.
IV. mole~ ef the PTPases
Only a few of the PTPases have a well characterized biological function. Information about PTPase function has been obtained from 'mutant" cells lacking the cnz~ne. CD45 ~s e.~l~ressed on the cell surface of iymphocytes and efforts were directed at the selection of cell lines lacking this surface marker. Because CD45 is critk~ to T-cell activation, cells lacking functional receptor PTPase have impaired response to T-cell [81, 82] , CD2 [83] , and B-cell receptor stimuli [84] . Intracellular signals induced by C'I~5 in T-cell activation include phosphoinositol turnover [85] and regulation of cellular serinL-kinases and phosphatases [76] . Three reviews regarding; "he biological activit7 of CD45 have recently appeared4 [86] [87] [88] .
Another PTPase wl.,me biological significance is known is the Yers/n/a Yop2B phosphatase. Sequence comparison of the catab tic core of m~malian PTPase slur, red that the bacterial Yop protein shared a numher of invariant residues with the lrfPases. Expression of the bacterial protein led to the discovery that it had phosphatase activity [20] . Honmlogous recombination of the genes encoding catalytically active and inactive enzymes conclusively showed that removal of this PTPase activity renders the bacteria avirulent [78] supporting the important observation that the phosphatase Fig. 3 . Suggested m~chanism for protein tyresine phosphatase. E-SH represents the enzyme with the catablic Cys residue. E-S-denotes the thio| anion of the PTPase which appears to the reactive form of the enz~3'ne. E-S-PO4H is the phosphoenz,~ne intermediate.
activity is essential for virulence in the pathogen which causes diseases such as the plague or the black death. For some time it had been known that p34 '~2, a scrine/thrconinc kinase contained in the mitosis-promoting factor (MPF) complex of higher eukaryotes, was negatively regulated by tyrosine and serine phosphorylation (reviewed in Ref. 89) . Genetic dissection of the system had identified a positive regulatory factor, termed edc25, that could induce the dephosphorylation of cde2 and taos entry into the cell cycle. Yeast mulants that lack active cdc25 can be induced to enter the cell cycle by the introduction of human T-cell PTPase [90:;. Thcrcfc,rc tyrosinc phosphatase activity was thought to be contained in or activa:ed by cdc25. Identification of Vhl [49] gave further impetus to this idea. Alignment of Vhl to edc25 (noted by Morcno and Nurse [91] ) showed discernible homology, espedally in the acth,-e-site region of the PTPase. This observation triggered several groups to test the phoP ph=tase activity of purified cdc25, cdc25 has a low-level phosphatase activity toward a very narrow set of substrates [63,64,92.93] . In all cases, p34 '~ was activated by removal of phosphate from its regulatory tyrosine. Parallel research has led to the identification of a PTPase, p65, that has both serine and tyrosinc phosphatase activity. This protein is a mitosis-specific component of human MPF [94] . Purified mitotic 1365 shows activity towards phosphotyrosine poly(Glu,Tyr) and serine/threonine-phosphorylated histone and phosphowiase a [95] . Further evidence supports the identity of this protein as the gene product of cdc25 [95] . The size difference between tbe predicted 54-kDa human cdc25 [48] and 65-kDa 1365 can presumably be accounted for by the latter's O-glycosylation. Conclusive identification awaits testing of both proteins with specific antibodies.
During the search for a PTPase responsible for activating p34 '~, two PTPase homologs from S. pombe and S. cereL-/s/ae were cloned and characterized [31, 32] . Tyrosine phusphatase activity was demonstrated for one of these PTPases [32] . Recently, Guan et al. [96] has reported the cloning of another S. ceret'isiae PTPase. Ota and Varshovsky [97] have also shown that this S. cerevisiae PTPase plays a role in the ubiquitin pathways that are important in protein degradation and in DNA repair.
Because of the growth activating and oncogenic functions of tyrosine kinases, the action of protein tyrosine pilosphatases functioning as tumor suppressor genes has also been considered. LaForgta and coworkers pursued this pos~ility by determining if there was a correlation between deletion of the genc for human PTP7 and the presence of tumors in humans [98] . Results indicated that one allele of the genc was lost in 3 of 5 renal carcinoma cell lines and 5 of 10 lung carcinoma lines. Other Fl'Pase genes have been 41 mapped to regions of chromosomes with frequent abnormalities associated with human cancer [35, 40] .
Another method used to identify potential functions of PTPases is to introduce these cata!~sts into cells and then to evaluate the biological effects of the PTPases. Biological effects observed, using this approach include blockage of insulin-like growth factor ! receptor autophosphorylation in Xenopus oocytes [99] , induction of meiotic cell division in Xenopus oocytes [100], reduction in baby hamster kidney cell growth rate [101] , stimulation of Ca2+-dependent amylase secretion from pancreatic acini [ 102] , reduction of transcriptional activation endowed by AP-I or CREB transcription factors [27] , and a reduction in the number of v-src [103] and p185 he° [104] transformed foci in NIH-3T3 cells. The exact position where each of these PTPases acts to produce these effects is unknown.
Expression of the PTPases in ceils have highlighted aspects of their cellular distributions. Cool and coworkers noted that most of the T-cell PTPase overexpressed in baby hamster kidney cells was associated with the insoluble membrane fraction [101] . Similar results were seen when the same PTPase was expressed in baculovirus [105] , where Triton X-100/KCI extractions were necessary to remove the enzyme activity from the cell pellet. Both results suggest a localizatiol: of T-cell PTPase to the membrane fraction, possibly through the hydrophobic amino acids at its Coterminus (see above). Results with human PTPIB are similar. Full length forms of ~he enzyme could only be isolated when the membranes were. solubilized in 2% Triton X-100 [106] . When PTPI was introduced into NIH 3T3 cells the protein was shown to localize to the endoplasmic retiealum and solubility studies indicate that PTPl had properties of an integral and not a peripheral membrane protein [103] . Recent observations by Neat and his colleagues indicate that the last 35 residues of PTP IB are responsible for this localization to the membrane [107] . Other studies have indicated novel cellular distributions of PTPases. These include the shift of different sized PTPase activities from the particulate to soluble fractions in megakaryocytic differentiating K562 cells [108] , a redistribution of CD45 from the Golgi to an unidentified intracellular location upon T-cell activation [109] , and the apparent movement of kidney cell PTPase activity from membranes to the cytosol upon cell coufluency, with a concomitant decrease in molecular weight and increase in activity [110] . A general activation of low-molecular-weight membrane tyrosine phosphatase activity has also been described by Pallen and Tong in density-dependent growth-arrested fibroblasts [111].
V. Concluding remarks
Knowledge of the protein tyrosine ph~sphatases has increased dramatically over the last year with the cloning of new cDNAS, the analysis of reccanbinant proteins' actions on substrates in vitro, deletion analysis of known PTPases in vivo to determine biological function, and the evaluation of tyrosine phosphatasc effects when introduced into a complex cellular system. It is a diverse and growing family with complex and not yet fully understood functions. It wculd appear that the proteins will have to be highly regulated, since most Hkely multiple PTPases will most likely occur in the same cell. The availability of cloned genes, pure proteins, and antibodies to these proteins will give future researchers the toois necessary to continue exploration of this interesting and complex family of regulatory proteins.
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